Recombinant multi-species CNOT6L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT6L protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable poly(A)-specific ribonuclease activity. Involved in positive regulation of cell population proliferation and positive regulation of cytoplasmic mRNA processing body assembly. Located in cytosol and nucleus. Part of CCR4-NOT complex. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 4932442K20Rik,CCR4-NOT transcription complex subunit 6-like,CCR4b,CNOT6L,Carbon catabolite repressor protein 4 homolog B,Cnot6l

Target products collectionGo to CNOT6L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6997-Ag-1/ GM-Tg-hg-IP6997-Ag-2 Human CNOT6L protein Human
GM-Tg-rg-IP6997-Ag-1/ GM-Tg-rg-IP6997-Ag-2 Rat CNOT6L protein Rat
GM-Tg-mg-IP6997-Ag-1/ GM-Tg-mg-IP6997-Ag-2 Mouse CNOT6L protein Mouse
GM-Tg-cynog-IP6997-Ag-1/ GM-Tg-cynog-IP6997-Ag-2 Cynomolgus/Rhesus macaque CNOT6L protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6997-Ag-1/ GM-Tg-felg-IP6997-Ag-2 Feline CNOT6L protein Feline
GM-Tg-cang-IP6997-Ag-1/ GM-Tg-cang-IP6997-Ag-2 Canine CNOT6L protein Canine
GM-Tg-bovg-IP6997-Ag-1/ GM-Tg-bovg-IP6997-Ag-2 Bovine CNOT6L protein Bovine
GM-Tg-equg-IP6997-Ag-1/ GM-Tg-equg-IP6997-Ag-2 Equine CNOT6L protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6997-Ag-1/ GM-Tg-hg-IP6997-Ag-2; GM-Tg-rg-IP6997-Ag-1/ GM-Tg-rg-IP6997-Ag-2;
GM-Tg-mg-IP6997-Ag-1/ GM-Tg-mg-IP6997-Ag-2; GM-Tg-cynog-IP6997-Ag-1/ GM-Tg-cynog-IP6997-Ag-2;
GM-Tg-felg-IP6997-Ag-1/ GM-Tg-felg-IP6997-Ag-2; GM-Tg-cang-IP6997-Ag-1/ GM-Tg-cang-IP6997-Ag-2;
GM-Tg-bovg-IP6997-Ag-1/ GM-Tg-bovg-IP6997-Ag-2; GM-Tg-equg-IP6997-Ag-1/ GM-Tg-equg-IP6997-Ag-2
Products Name CNOT6L protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CNOT6L
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT6L protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.